Galapagos reported €-28126000 in EBITDA for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
AstraZeneca AZN:LN 2236M 118M
Biogen BIIB:US $ 1293.5M 829.7M
Gilead Sciences GILD:US $ -2633M 5384M
GlaxoSmithKline GSK:LN 1750M 932M
Merck MRK:GR € 1089M 70M
Neurocrine Biosciences NBIX:US $ 124M 63M
Vertex Pharmaceuticals VRTX:US $ 753.93M 5.28M
YTE INCY:US $ 262.67M 904.82M